Simulation Education for Ebola Healthcare Team Competency
Simulation Education for Ebola Healthcare Team Competency
批准号:
9199265
负责人:
JOSEPH G REVES
金额:
$15.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2017-08-31
中文摘要
项目摘要
埃博拉和其他致命的病毒性疾病对这个国家构成了重大威胁。美国疾病控制中心
控制和预防(CDC)呼吁SBIR项目重点支持埃博拉安全
关于病毒传播、疾病防控和公共卫生准备。此SBIR地址
这一需求与名为医疗单位专业模拟培训(MUSST)的教育产品有关。
MUSST包括1)基于互联网的对高风险传染性科学背景的自我研究
疾病,特别强调埃博拉病毒的诊断、传染性和传播2)快速学习的训练
培训师互联网自我管理组件,用于医院教师授课,3)疾控中心和
基于NIOSH指南的15种常见模拟任务的安全操作规程,供护士、医生和
其他单位工作人员,以及4)自动评分和数据获取系统,可立即评分和
对学员的表现进行排名,以便医院领导和管理人员能够确保其员工已学习到
并掌握了高风险单位的常见任务。MUSST将标准化教育和安全做法
在全国范围内保护我们的医护人员的安全,并帮助遏制致命的传染性
疾病。
在第一阶段,有两个不同的目标。目标1是创建一个全面的数字学习系统
关于当前的医学、CDC和OSHA指导方针,这些指导方针教导教师在15年内教育他们的员工
共同的任务和职责,并提供对学员员工表现的自动评分和排名。一个
拥有埃博拉病毒病教学和掌握教育专业知识的科学顾问委员会将验证
目的1.目的2,通过对医院工作人员志愿者的中试,考察其效度、有效性
和培训模块学习系统的可靠性。初步研究检验了区分效度,内部效度。
评分员的可靠性和MUSST组件的有效性。第二阶段是产品开发的关键
确保:1)MUSST的效度、信度和效度得到完善,并用权力进行检验
在第一阶段了解到的估计;2)该软件可以在大多数医院的通用平台上运行;
3)MUSST可以被其他医院的工作人员成功使用;4)学习掌握的衰败
学习-确定工人必须经历模拟才能保持安全的频率。
市场上的许多力量确保了这一无与伦比的教育产品的成功。许多医院
不能开发自己的课程,必须购买有效产品。像OSHA这样的医院监管机构
联合委员会已将保护工人和遏制埃博拉病毒列为一项要求。
这些力量,以及SimTunes与
最大的高保真模拟制造商(Laerdal),最大的医院教育内容提供商
(HealthStream),以及SimTunes产品之前的产品成功,都承诺确保MUSST的成功。
英文摘要
Project Summary
Ebola and other deadly viral diseases represent a major threat to the nation. The Centers for Disease
Control and Prevention (CDC) have called for SBIR projects that focus on support for Ebola Safety with a focus
on virus transmission, disease prevention and control, and public health preparedness. This SBIR addresses
this need with the educational product named Medical Unit Specialized Simulation Training (MUSST.)
MUSST contains 1) internet based self-study of the scientific background for high stakes infectious
disease with special emphasis on the diagnosis, infectivity, transmission of the Ebola 2) a rapidly learned train
the trainer internet self-administered component for hospital instructors to teach the course, 3) CDC and
NIOSH guideline based safe practice protocols for 15 common simulated tasks for nurses, physicians and
other unit workers, and 4) an automated scoring and data acquisition system that immediately grades and
ranks performance of learners so that hospital leaders and administrators can insure their staff have learned
and mastered the common tasks in a high risk unit. MUSST will standardize education and safe practices
across the country keeping our healthcare workers safe and helping in the containment of deadly infectious
disease.
In Phase I there are 2 distinct aims. Aim 1 is to create a comprehensive digital learning system based
on current medical science, CDC and OSHA guidelines that teach teachers to educate their workforce in 15
common tasks and duties and provides automated scoring and ranking of performance of learner staff. A
scientific advisory board with Ebola Viral Disease teaching and Mastery Education expertise will validate the
content in Aim 1. Aim 2, using pilot testing of hospital worker volunteers, investigates the validity, effectiveness
and reliability of the training modules learning system. The pilot studies test the discrimination validity, inter-
rater reliability, and effectiveness of MUSST components. Phase II is essential to product development
insuring that: 1) that the validity, reliability and effectiveness of MUSST are perfected and tested using power
estimates learned in Phase I; 2) the software can run on the commonly available platforms at most hospitals;
3) that MUSST can be successfully used by workers at other hospitals and; 4) learn the decay of mastery
learning – determine how often workers have to undergo the simulation to stay safe.
Many forces in the market assure the success of this unrivaled educational product. Many hospitals
cannot develop their own course and must purchase a valid product. Hospital regulatory agencies like OSHA
and The Joint Commission have made the protection of workers and containment of Ebola a requirement.
These forces along with product promotion by the firmly established corporate alliances of SimTunes with the
largest high fidelity simulation manufacturer (Laerdal), the largest hospital educational content provider
(HealthStream), and prior product success of SimTunes products all promise to insure success of MUSST.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GENERAL CLINICAL RESEARCH CENTER
-
批准号:7953527
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2009
-
负责人:JOSEPH G REVES
-
依托单位:
General Clinical Research Center
-
批准号:7590486
-
项目类别:
-
资助金额:$0.57万
-
财政年份:1997
-
负责人:JOSEPH G REVES
-
依托单位:
General Clinical Research Center
-
批准号:7302746
-
项目类别:
-
资助金额:$200.34万
-
财政年份:1997
-
负责人:JOSEPH G REVES
-
依托单位:
General Clinical Research Center
-
批准号:7477254
-
项目类别:
-
资助金额:$196.34万
-
财政年份:1997
-
负责人:JOSEPH G REVES
-
依托单位:
AGING AND COGNITION AFTER CARDIAC SURGERY
-
批准号:3121574
-
项目类别:
-
资助金额:$22.8万
-
财政年份:1991
-
负责人:JOSEPH G REVES
-
依托单位:
AGING AND COGNITION AFTER CARDIAC SURGERY
-
批准号:2766666
-
项目类别:
-
资助金额:$33.29万
-
财政年份:1991
-
负责人:JOSEPH G REVES
-
依托单位:
AGING AND COGNITION AFTER CARDIAC SURGERY
-
批准号:2050940
-
项目类别:
-
资助金额:$38.48万
-
财政年份:1991
-
负责人:JOSEPH G REVES
-
依托单位:
AGING AND COGNITION AFTER CARDIAC SURGERY
-
批准号:2050941
-
项目类别:
-
资助金额:$34.65万
-
财政年份:1991
-
负责人:JOSEPH G REVES
-
依托单位:
AGING AND COGNITION AFTER CARDIAC SURGERY
-
批准号:3121575
-
项目类别:
-
资助金额:$20.94万
-
财政年份:1991
-
负责人:JOSEPH G REVES
-
依托单位:
AGING AND COGNITION AFTER CARDIAC SURGERY
-
批准号:2050942
-
项目类别:
-
资助金额:$35.99万
-
财政年份:1991
-
负责人:JOSEPH G REVES
-
依托单位:
AGING AND COGNITION AFTER CARDIAC SURGERY
-
批准号:2330192
-
项目类别:
-
资助金额:$37.39万
-
财政年份:1991
-
负责人:JOSEPH G REVES
-
依托单位:
AGING AND COGNITION AFTER CARDIAC SURGERY
-
批准号:6149912
-
项目类别:
-
资助金额:$34.0万
-
财政年份:1991
-
负责人:JOSEPH G REVES
-
依托单位:
AGING AND COGNITION AFTER CARDIAC SURGERY
-
批准号:3121576
-
项目类别:
-
资助金额:$15.22万
-
财政年份:1991
-
负责人:JOSEPH G REVES
-
依托单位:
AGING AND COGNITION AFTER CARDIAC SURGERY
-
批准号:6349722
-
项目类别:
-
资助金额:$34.73万
-
财政年份:1991
-
负责人:JOSEPH G REVES
-
依托单位:
AGING AND COGNITION AFTER CARDIAC SURGERY
-
批准号:2653728
-
项目类别:
-
资助金额:$26.8万
-
财政年份:1991
-
负责人:JOSEPH G REVES
-
依托单位:
GENERAL CLINICAL RESEARCH CENTER
-
批准号:6322563
-
项目类别:
-
资助金额:$201.49万
-
财政年份:1977
-
负责人:JOSEPH G REVES
-
依托单位:
GENERAL CLINICAL RESEARCH CENTER
-
批准号:6637720
-
项目类别:
-
资助金额:$210.09万
-
财政年份:1977
-
负责人:JOSEPH G REVES
-
依托单位:
GENERAL CLINICAL RESEARCH CENTER
-
批准号:6706362
-
项目类别:
-
资助金额:$207.74万
-
财政年份:1977
-
负责人:JOSEPH G REVES
-
依托单位:
GENERAL CLINICAL RESEARCH CENTER
-
批准号:6531156
-
项目类别:
-
资助金额:$254.92万
-
财政年份:1977
-
负责人:JOSEPH G REVES
-
依托单位:
GENERAL CLINICAL RESEARCH CENTER
-
批准号:6865620
-
项目类别:
-
资助金额:$201.6万
-
财政年份:1977
-
负责人:JOSEPH G REVES
-
依托单位:
海外基金